The Rise in Prevalence and Related Costs of Nontuberculous Mycobacterial Diseases in South Korea, 2010

The Rise in Prevalence and Related Costs of Nontuberculous Mycobacterial Diseases in South Korea, 2010–2021

Published:2022-12-01 Issue:12 Volume:9 Page:
ISSN:2328-8957
Container-title:Open Forum Infectious Diseases
language:en
Short-container-title:

Author:

Kim Joong-Yub¹,Kwak Nakwon¹,Yim Jae-Joon¹

Affiliation:

1. Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Seoul National University Hospital, Seoul National University College of Medicine , Seoul , Republic of Korea

Abstract

Abstract Between 2010 and 2021, the annual prevalence of nontuberculous mycobacterial (NTM) diseases in South Korea increased from 11.4 to 56.7 cases per 100 000 population. Prevalence in the population aged ≥65 years quadrupled from 41.9 to 163.1 cases per 100 000 population. Accordingly, the overall cost associated with NTM diseases increased.

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Oncology

Link

https://academic.oup.com/ofid/advance-article-pdf/doi/10.1093/ofid/ofac649/47471736/ofac649.pdf

Reference12 articles.

1. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases;Griffith;Am J Respir Crit Care Med,2007

2. Epidemiology of nontuberculous mycobacterial infection, South Korea, 2007–2016;Lee;Emerg Infect Dis,2019

3. Prevalence of nontuberculous mycobacterial lung disease in U. S. Medicare beneficiaries;Adjemian;Am J Respir Crit Care Med,2012

4. Non-tuberculous mycobacterial pulmonary disease;Cowman;Eur Respir J,2019

5. Thirty years of national health insurance in South Korea: lessons for achieving universal health care coverage;Kwon;Health Policy Plan,2009

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chemical optimization and derivatization of micrococcin p2 to target multiple bacterial infections: new antibiotics from thiopeptides;World Journal of Microbiology and Biotechnology;2024-08-20

2. PARK2 as a susceptibility factor for nontuberculous mycobacterial pulmonary disease;Respiratory Research;2024-08-14

3. Immunologic features of nontuberculous mycobacterial pulmonary disease based on spatially resolved whole transcriptomics;BMC Pulmonary Medicine;2024-08-13

4. The Impact of Trehalose Dimycolate on the Clinical Course of Mycobacterium avium Complex Pulmonary Disease;Annals of the American Thoracic Society;2024-07

5. Epidemiological Characteristics of Nontuberculous Mycobacterial Pulmonary Disease in South Korea: A Meta-analysis of Individual Participant Data;Tuberculosis and Respiratory Diseases;2024-07-01